HNHanan Nasir

Hanan Nasir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hanan Nasir has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of chlorpyrifos and acephate on the web-building behavior of Argiope trifasciata

    by S. Ashraf, M. Arshad, R. Yaqoob, A. Gull, R. Aslam, S. Mulazim, M. Ali, H. Nasir, Qurat- Ul- Ain, K. Batool, et al.

    Traditionally, various agricultural practices are used to increase agricultural yield along with insecticides. Excessive utilization of insecticides in crops has harmful effects on natural predators by reducing their efficiency as biological control agents. In this study, the harmful effects of insecticides such as chlorpyrifos and acephate on the web-building behavior of Argiope trifasciata were observed with different concentrations and time gaps. The mortality rate of spiders was also recorded; for example, 30% mortality was observed after exposure to field-rate concentration of acephate, while 20% and 5% mortality were observed after exposure to intermediate and half-field concentrations of acephate, respectively. Similarly, 50% mortality was observed at field-rate concentration of chlorpyrifos. However, 20% and 10% mortality were observed after the application of chlorpyrifos at intermediate and half-field concentrations, respectively. Both insecticides maximally influenced the web parameters after 72 h of exposure at field-rate concentration. However, chlorpyrifos adversely affected the web parameters compared to acephate.

  • Open Access

    Polymorphic and Expressional Analysis of Genes CDKN2B and ADIPOQ in Cardiovascular Patients Using Conventional and qPCR Approach

    by Kashif Bashir, Sayeda Fatima Tuba Sidra Batool, Sana Zahra, Hanan Nasir, Muhammad Umar, Tooba Ashraf

    Background: In the modern age, the problem of heart disease is increasing day by day which cause even more deaths than cancer. The study was designed to evaluate the polymorphism and expressional analysis of genes CDKN2B and ADIPOQ in cardiovascular patients. Methodology: Blood samples of 300 cardiovascular patients and 300 controls were collected from Gannan and other hospitals of Pakistan. For polymorphism analysis, DNA was extracted followed, by conventional PCR to amplify the variants rs4977574, rs2383206, and rs2241766 of genes CDKN2B and ADIPOQ, respectively. For expressional analysis, mRNA was extracted from whole blood and converted into cDNA, followed by qPCR. Results: The results show that heterozygous (AG) of rs4977574 of the CDKN2B gene showed highly significant association with 2‐folds increased risk of cardiovascular disease (CVD) (OR = 2.03; 95% Cl = 1.26–3.25; p < 0.0033) while heterozygous (AG) of rs2383206 of the gene CDKN2B exhibited significant association but with decreased risk of CVD (OR = 0.47; 95% Cl = 0.29–0.75; p < 0.0017). The results of ADIPOQ polymorphism rs2241766 show that the heterozygous genotype (TG) showed a significant association with a decreased risk of CVD (OR = 0.63; 95% CI = 0.39–1.01; p < 0.05) while the homozygous mutant genotype (GG) of rs2241766 again showed a highly significant association with CVD which increased the risk of CVD by 2‐folds (OR = 1.77; 95% CI = 1.11–2.80; p < 0.0150). The results of expressional analysis show that CDKN2B is significantly overexpressed in cardiovascular patients, while the gene ADIPOQ showed significant downregulation. Conclusion: The findings show that the CDKN2B and ADIPOQ gene polymorphisms significantly raise the risk for CVD, while their expression shows a significant correlation with CVD .